| RE49556 |
Compounds and compositions as protein kinase inhibitors |
Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, Yongqin Wan +2 more |
2023-06-20 |
|
| 10576080 |
Compounds and compositions as protein kinase inhibitors |
Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, Yongqin Wan +2 more |
2020-03-03 |
|
| 10568884 |
Compounds and compositions as protein kinase inhibitors |
Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, Yongqin Wan +2 more |
2020-02-25 |
|
| 10005761 |
Compounds and compositions as protein kinase inhibitors |
Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, Yongqin Wan +2 more |
2018-06-26 |
$22,336,000 |
| 9850229 |
Compounds and compositions as protein kinase inhibitors |
Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, Yongqin Wan +2 more |
2017-12-26 |
$17,434,000 |
| 9850230 |
Compounds and compositions as protein kinase inhibitors |
Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, Yongqin Wan +2 more |
2017-12-26 |
$17,434,000 |
| 9593099 |
Compounds and compositions as protein kinase inhibitors |
Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, Yongqin Wan +2 more |
2017-03-14 |
$22,656,000 |
| 9593100 |
Compounds and compositions as protein kinase inhibitors |
Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, Yongqin Wan +2 more |
2017-03-14 |
$22,656,000 |
| 9580426 |
Compounds that expand hematopoietic stem cells |
Anthony Boitano, Michael Cooke, Shifeng Pan, Peter G. Schultz, Yongqin Wan +1 more |
2017-02-28 |
$10,709,000 |
| 9314464 |
Compounds and compositions as protein kinase inhibitors |
Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, Yongqin Wan +2 more |
2016-04-19 |
$9,947,000 |
| 9181238 |
N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitors |
Shifeng Pan, Yongqin Wan, Yongping Xie, Xing Wang, Xia Wang +3 more |
2015-11-10 |
$11,211,000 |
| 8927281 |
Method for expanding hematopoietic stem cells |
Anthony Boitano, Michael Cooke, Shifeng Pan, Peter G. Schultz, Yongqin Wan +1 more |
2015-01-06 |
|
| 8859548 |
Compounds and compositions as protein kinase inhibitors |
Abran Q. Costales, Shenlin Huang, Jeff Jin, Zuosheng Liu, Sabina Pecchi +2 more |
2014-10-14 |
$8,790,000 |
| 8563553 |
Compounds and compositions as protein kinase inhibitors |
Abran Q. Costales, Shenlin Huang, Jeff Jin, Zuosheng Liu, Sabina Pecchi +1 more |
2013-10-22 |
$8,956,000 |
| 8501758 |
Compounds and compositions as protein kinase inhibitors |
Shenlin Huang, Xianming Jin, Zuosheng Liu, Daniel Poon, Yongqin Wan +2 more |
2013-08-06 |
$7,772,000 |
| 8242260 |
Compounds and compositions as protein kinase inhibitors |
Abran Q. Costales, Shenlin Huang, Jeff Jin, Zuosheng Liu, Sabina Pecchi +2 more |
2012-08-14 |
$12,923,000 |
| 7879862 |
Pyrazolo[1,5-alpha]pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists |
Marion Lanier, John Williams |
2011-02-01 |
|
| 7652035 |
CRF receptor antagonists and methods relating thereto |
Marion Lanier, Manisha Moorjani, John Williams |
2010-01-26 |
|
| 6852745 |
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
Natesan Murugesan, John E. Macor, Zhengxiang Gu |
2005-02-08 |
$84,215,000 |
| 6835741 |
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
Natesan Murugesan, John E. Macor, Zhengxiang Gu |
2004-12-28 |
$65,456,000 |
| 6638937 |
Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
Natesan Murugesan, John E. Macor, Zhengxiang Gu |
2003-10-28 |
$54,013,000 |
